Press Releases

Pharmaceutical Drug Delivery Market Size to Gain US$ 2,047.36 Billion by 2030

The global pharmaceutical drug delivery market size is forecasted to reach from US$ 1,476.19 billion in 2021 to US$ 2,047.36 billion by 2030 and is anticipated to grow at compounded annual growth rate (CAGR) of 3.7% from 2021 to 2030, as per reports by market research and consulting organization Precedence Research.

Pharmaceutical Drug Delivery Market (By Route of Administration: Oral, Pulmonary, Ocular, Nasal, Injectable, Topical, and Others; By Application: Cardiovascular, Diabetes, Cancer, Infectious Diseases, and Others; By End Users: Hospitals, Ambulatory Services, and Home Healthcare) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2021 – 2030

The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 to 2020, the forecast period considered is from 2021 to 2030. The pharmaceutical drug delivery market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit). The report offers exclusive insights to help companies make informed decision to sustain growth through the assessment period.

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1453

The global pharmaceutical drug delivery market is primarily driven by the growing burden of various chronic diseases such as diabetes, cancer, and cardiovascular diseases among the population. The rapidly growing biopharmaceuticals industry encouraged the development of several innovative pharmaceutical drugs that can effectively treat various non-communicable diseases. The rapidly growing diabetic population is augmenting the demand for the pharmaceutical drug delivery solutions as the diabetic patients need regular administration of insulin to manage their blood glucose levels.

The growing popularity and adoption of the needle-free injectors, self-injectors, auto-injectors, and pen-injectors has enabled the patients to conveniently administer drugs from the convenience of their home, eliminating the medical assistance. Moreover, the rising investments by the top market players in the research and development and clinical trials of the pharmaceutical drug delivery solutions are spurring the market growth. Furthermore, the proliferation of technologies has offered easy to use and convenient administration of drugs through various roots, which is significantly driving the pharmaceutical drug delivery market, globally.

Scope of the Pharmaceutical Drug Delivery Market

Report Coverage Details
Market Size in 2021 USD 1,476.19 Billion
Growth Rate CAGR of 3.7%
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Segments Covered Route of Administration, Application, End User, Region

Some of the leading companies operating in the pharmaceutical drug delivery market are profiled in the market study. The report also underscores winning strategies adopted over the last few years and gauges impact of the same on growth trajectory exhibited by the market over the last few years.

Major companies operating in this report are

  • Bayer AG
  • Becton, Dickinson And Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • 3M Company
  • Pfizer Inc.
  • Sanofi

Market Dynamics

Driver

Growing burden of chronic diseases

According to the International Agency for Research on Cancer, in 2020, around 19.3 million new cancer cases and 10 million cancer deaths were reported across the globe. The global cancer cases are estimated to grow by 47% from 2020 to 2040. It is expected that 28.4 million cases will be recorded in 2040, globally. According to the World Health Organization, the cardiovascular diseases results in around 17.9 million or 32% of the global deaths and it is a leading cause of death across the globe. As per the International Diabetes Federation, the global diabetic population is estimated to reach at 783 million by 2045. Therefore, the rapidly rising burden of various non-communicable diseases is expected to drive the demand for the pharmaceutical drug delivery solutions in the forthcoming years.

Restraints

Risks of needle stick injuries may hamper the market growth

With the growing demand for the pharmaceutical drug delivery solution, the risks of getting needle stick injuries are also growing. According to the US CDC, around 385,000 needle stick injuries occur annually in US. Therefore, the rising number of such injuries may hinder the market growth during the forecast period.

Opportunities

Growing adoption of homecare and self-administration of drugs

The proliferation of the advanced technologies has enabled the patients to self-administer the drugs by eliminating the assistance of healthcare professionals. This saves time and cost of the patients. The diabetic population has higher demand as they regularly needs insulin injections and the pen injectors, needle free injectors, and auto-injectors are trending in the market.

Challenges

Government regulations on pricing

The government authorities across the developing and developed nations are promoting cost-cutting measures and encouraging the use of generics. The manufacturers of the pharmaceutical drug delivery solutions are facing pressure to reduce the cost of the solutions.

Report Highlights

  • Based on the route of administration, the topical segment is estimated to be the most opportunistic market during the forecast period. This is attributed to the several benefits associated with the topical route of administration such as non-invasiveness, ease of use, convenience, and painless drug delivery.
  • Based on the application, the cancer segment dominated the global pharmaceutical drug delivery market, due to the rising prevalence of cancer among the global population. According to the International Agency for Research on Cancer, in 2020, around 19.3 million new cancer cases and 10 million cancer deaths were reported across the globe. The global cancer cases are estimated to grow by 47% from 2020 to 2040. It is expected that 28.4 million cases will be recorded in 2040, globally.
  • Based on the end user, the home healthcare segment is expected to be the most opportunistic segment owing to the growing geriatric population, rising disposable income, and rising awareness regarding the hospital acquired infections.

Regional Snapshot

North America dominated the global pharmaceutical drug delivery market in 2020. The increased prevalence of various chronic diseases among the US population coupled with increased healthcare expenditure has fostered the market growth in the region. It is estimated that around 60% of the US population is suffering from one or more chronic diseases. The increased government investments and the favorable regulatory framework are fueling the growth of the biopharmaceutical industry in the region, which is a major reason behind the growth of the pharmaceutical drug delivery market in North America.

Asia Pacific is estimated to be the most opportunistic market during the forecast period. The presence of few top biotechnology companies in the nations like South Korea, India, and China is augmenting the market growth. The presence of huge population and growing burden of chronic diseases like CVDs, cancer, respiratory disorders, and diabetes among the population is a major factor that propels the market growth in Asia Pacific. The rising adoption of the personalized medicines in the region is expected to have a positive impact on the market growth.

Segments Covered in the Report

By Route of Administration

  • Oral
  • Ocular
  • Pulmonary
  • Nasal
  • Injectable
  • Topical
  • Others

By Application

  • Cardiovascular
  • Diabetes
  • Cancer
  • Infectious Diseases
  • Others

By End User

  • Hospitals
  • Ambulatory Services
  • Home Healthcare

Regional Segmentation

– North America (U.S. and Canada)

 – Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)

 – Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)

 – Latin America (Brazil and Rest of Latin America)

– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Why should you invest in this report?

If you are aiming to enter the global pharmaceutical drug delivery market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for pharmaceutical drug delivery are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Purchase Full Research Report @ https://www.precedenceresearch.com/checkout/1453

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Pharmaceutical Drug Delivery Market 

5.1. COVID-19 Landscape: Pharmaceutical Drug Delivery Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Pharmaceutical Drug Delivery Market, By Route of Administration

8.1. Pharmaceutical Drug Delivery Market, by Route of Administration Type, 2021-2030

8.1.1. Oral

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Ocular

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Pulmonary

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Nasal

8.1.4.1. Market Revenue and Forecast (2019-2030)

8.1.5. Injectable

8.1.5.1. Market Revenue and Forecast (2019-2030)

8.1.6. Topical

8.1.6.1. Market Revenue and Forecast (2019-2030)

8.1.7. Others

8.1.7.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Pharmaceutical Drug Delivery Market, By Application

9.1. Pharmaceutical Drug Delivery Market, by Application, 2021-2030

9.1.1. Cardiovascular

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Diabetes

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Cancer

9.1.3.1. Market Revenue and Forecast (2019-2030)

9.1.4. Infectious Diseases

9.1.4.1. Market Revenue and Forecast (2019-2030)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Pharmaceutical Drug Delivery Market, By End User 

10.1. Pharmaceutical Drug Delivery Market, by End User, 2021-2030

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2019-2030)

10.1.2. Ambulatory Services

10.1.2.1. Market Revenue and Forecast (2019-2030)

10.1.3. Home Healthcare

10.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Pharmaceutical Drug Delivery Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Route of Administration (2019-2030)

11.1.2. Market Revenue and Forecast, by Application (2019-2030)

11.1.3. Market Revenue and Forecast, by End User (2019-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Route of Administration (2019-2030)

11.1.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.1.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Route of Administration (2019-2030)

11.1.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.1.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Route of Administration (2019-2030)

11.2.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.3. Market Revenue and Forecast, by End User (2019-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Route of Administration (2019-2030)

11.2.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Route of Administration (2019-2030)

11.2.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Route of Administration (2019-2030)

11.2.6.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.6.3. Market Revenue and Forecast, by End User (2019-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Route of Administration (2019-2030)

11.2.7.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.7.3. Market Revenue and Forecast, by End User (2019-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Route of Administration (2019-2030)

11.3.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.3. Market Revenue and Forecast, by End User (2019-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Route of Administration (2019-2030)

11.3.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Route of Administration (2019-2030)

11.3.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Route of Administration (2019-2030)

11.3.6.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.6.3. Market Revenue and Forecast, by End User (2019-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Route of Administration (2019-2030)

11.3.7.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.7.3. Market Revenue and Forecast, by End User (2019-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Route of Administration (2019-2030)

11.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Route of Administration (2019-2030)

11.4.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Route of Administration (2019-2030)

11.4.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Route of Administration (2019-2030)

11.4.6.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.6.3. Market Revenue and Forecast, by End User (2019-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Route of Administration (2019-2030)

11.4.7.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.7.3. Market Revenue and Forecast, by End User (2019-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Route of Administration (2019-2030)

11.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Route of Administration (2019-2030)

11.5.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.5.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Route of Administration (2019-2030)

11.5.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.5.5.3. Market Revenue and Forecast, by End User (2019-2030)

Chapter 12. Company Profiles

12.1. Bayer AG

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Becton, Dickinson And Company

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. F. Hoffmann-La Roche AG

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. GlaxoSmithKline Plc

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Johnson & Johnson

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Merck & Co., Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Novartis AG

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. 3M Company

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Pfizer Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Sanofi

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1453

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Show More

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button